Powered by Blogger.

Blog Archive

Saturday, November 30, 2013

By Rob Sutter


When it comes to glioblastoma, it seems as though there are many points to take into account. This is seen as one of the most common forms of cancer in the body, which cannot be overlooked. As a result, you can imagine that there are a number of different strategies that can come into effect, each of them being looked into. However, what if I was to tell you that there is a drug that can help this particular condition, which has been given a great deal of recognition?

As stated before, glioblastoma is the most common type of cancer in the brain but I do not know how many people truly understand just how important it is. Keep in mind that it is the most aggressive form of the condition as well, a point that is covered by organizations along the lines of Voices against Brain Cancer. As you can imagine, therapies are made with this condition serving as something of a centerpiece. That being said, what is the type of drug that was referred to before?

This was given the name of J101 and it was covered in a report posted on Labmate Online. Scientists working within the Samantha Dickinson Brain Cancer Unit put together studies for the sake of administering drugs, testing each of them to see the results that could come about. What was found, though, was that J101 was able to stop the growth of these cancerous cells. In addition, it could serve its purpose while leaving the healthy brain tissue unharmed, making it all the more useful.

You may be wondering what exactly is entailed when it comes to J101. If you are curious, keep in mind that kinase is the component that is required in order to send many signals to the cells in the body, whether it is to allow them to grow or replicate. J101 is able to halt the processes of kinase, meaning that the cells in the brain do not have the change to go about either process. It is an important point, to say the least, when it comes to the medical field.

In the aforementioned medical field, there is a great amount of emphasis placed on particular drugs. It's important to see which ones are going to prove most useful and I have to believe that J101 is just one of the examples that can, at the very least, aid in the way of glioblastoma awareness. It seems as though many components can be brought into effect. It's just a matter of incorporating them in the best of ways so that they can stand that much taller.




About the Author:



0 comments:

Post a Comment